BlackRock, Inc. 13D and 13G filings for Pieris Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-07-12 08:29 am Sale | 2021-06-30 | 13G | Pieris Pharmaceuticals, Inc. PIRS | BLACKROCK INC BLK | 16,281 2.100% | -29,111 (-64.13%) | Filing |
| 2021-01-29 5:23 pm Purchase | 2020-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS | BLACKROCK INC BLK | 45,391 6.500% | 2,827 (+6.64%) | Filing |